Mission Bio Raises $30M to Scale the First-ever Platform Aimed at Predicting and Preventing Cancer Relapse with Single-Cell Genomics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2ExMQXM
via IFTTT